278 related articles for article (PubMed ID: 1082854)
21. Tissue specificity of antinuclear antibodies in scleroderma.
Błaszczyk M; Beutner EH; Rogoziński T; Rzesa G; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski TP
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):761-4. PubMed ID: 107922
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous expression of antibodies to DNA of various species origin in sera of normal subjects and patients with systemic lupus erythematosus.
Karounos DG; Grudier JP; Pisetsky DS
J Immunol; 1988 Jan; 140(2):451-5. PubMed ID: 3257238
[TBL] [Abstract][Full Text] [Related]
23. [Kinetoplast of the flagellate crithidia luciliae: a suitable substrate for the detection of antibodies to native, double-stranded DNA in the indirect immuno-fluorescence test (author's transl)].
Stingl G; Knapp W
Wien Klin Wochenschr; 1975 Dec; 87(24):827-9. PubMed ID: 775803
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans.
Muryoi T; Sasaki T; Harata N; Takai O; Tamate E; Yoshinaga K
Clin Exp Immunol; 1988 Jan; 71(1):67-72. PubMed ID: 3258206
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
[TBL] [Abstract][Full Text] [Related]
26. Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.
Mahler M; Greidinger EL; Szmyrka M; Kromminga A; Fritzler MJ
Ann N Y Acad Sci; 2007 Aug; 1109():311-21. PubMed ID: 17785320
[TBL] [Abstract][Full Text] [Related]
27. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
Sjoholm AG; Martensson U; Sturfelt G
J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
29. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
30. Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus.
Koike T; Sueishi M; Funaki H; Tomioka H; Yoshida S
Clin Exp Immunol; 1984 Apr; 56(1):193-9. PubMed ID: 6201309
[TBL] [Abstract][Full Text] [Related]
31. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Kumar S; Isenberg DA
Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
34. [IgG-type antihistone antibodies. Diagnostic value in rheumatoid polyarthritis, scleroderma, spontaneous and drug-induced lupus].
Meyer O; Cyna L; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 Jun; 51(6):303-10. PubMed ID: 6382565
[TBL] [Abstract][Full Text] [Related]
35. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
[TBL] [Abstract][Full Text] [Related]
36. Antinucleolar autoantibodies demonstrated by monolayers of human fibroblasts in sera from patients with systemic lupus erythematosus, progressive systemic sclerosis and chronic active hepatitis.
Kenneally D; Mackay IR; Toh BH
J Clin Lab Immunol; 1984 May; 14(1):13-6. PubMed ID: 6748043
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of antigodies binding polyinosinic-polycytidylic acid in human and mouse lupus sera by viral and synthetic ribonucleic acids.
Talal N; Steinberg AD; Daley GG
J Clin Invest; 1971 Jun; 50(6):1248-52. PubMed ID: 4325310
[TBL] [Abstract][Full Text] [Related]
38. [Enzyme linked immunosorbent assay to detect antinucleic acid antibodies (anti-DNA and anti-RNA antibodies) (author's transl)].
Ait Kaci AA; Monier JC
Pathol Biol (Paris); 1982 Feb; 30(2):73-8. PubMed ID: 6178071
[TBL] [Abstract][Full Text] [Related]
39. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
40. Characterization of DNA used to assay sera for anti-DNA antibodies; determination of the specificities of anti-DNA antibodies in SLE and non-SLE rheumatic disease states.
Locker JD; Medof ME; Bennett RM; Sukhupunyaraksa S
J Immunol; 1977 Feb; 118(2):694-701. PubMed ID: 300090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
